Baillie Gifford & Co’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.6M Buy
582,598
+1,157
+0.2% +$90.5K 0.03% 154
2025
Q1
$42.1M Sell
581,441
-125,355
-18% -$9.09M 0.04% 150
2024
Q4
$52.3M Buy
706,796
+498,100
+239% +$36.9M 0.04% 143
2024
Q3
$13.8M Sell
208,696
-143,607
-41% -$9.48M 0.01% 197
2024
Q2
$32.5M Sell
352,303
-44,250
-11% -$4.09M 0.03% 159
2024
Q1
$37.9M Sell
396,553
-7,405
-2% -$708K 0.03% 162
2023
Q4
$30.8M Sell
403,958
-36,443
-8% -$2.78M 0.02% 175
2023
Q3
$30.5M Sell
440,401
-23,639
-5% -$1.64M 0.03% 169
2023
Q2
$43.8M Sell
464,040
-3,444
-0.7% -$325K 0.04% 158
2023
Q1
$38.7M Buy
467,484
+31,993
+7% +$2.65M 0.03% 158
2022
Q4
$32.5M Buy
435,491
+3,345
+0.8% +$250K 0.03% 166
2022
Q3
$35.7M Buy
432,146
+11,921
+3% +$985K 0.04% 158
2022
Q2
$40M Sell
420,225
-5,000
-1% -$475K 0.04% 164
2022
Q1
$50.1M Sell
425,225
-7,463
-2% -$879K 0.04% 174
2021
Q4
$56.1M Buy
432,688
+11,143
+3% +$1.44M 0.03% 176
2021
Q3
$47.7M Buy
421,545
+17,758
+4% +$2.01M 0.03% 186
2021
Q2
$41.8M Sell
403,787
-1,170
-0.3% -$121K 0.02% 200
2021
Q1
$33.9M Buy
404,957
+124,646
+44% +$10.4M 0.02% 204
2020
Q4
$25.6M Buy
280,311
+26,830
+11% +$2.45M 0.01% 190
2020
Q3
$20.2M Buy
253,481
+58,738
+30% +$4.69M 0.01% 182
2020
Q2
$13.5M Buy
194,743
+191,332
+5,609% +$13.2M 0.01% 186
2020
Q1
$214K Sell
3,411
-357
-9% -$22.4K ﹤0.01% 211
2019
Q4
$293K Hold
3,768
﹤0.01% 212
2019
Q3
$276K Sell
3,768
-213
-5% -$15.6K ﹤0.01% 213
2019
Q2
$245K Hold
3,981
﹤0.01% 220
2019
Q1
$254K Hold
3,981
﹤0.01% 220
2018
Q4
$203K Buy
+3,981
New +$203K ﹤0.01% 219